mTor pathway common in multiple Neuro degenerative diseases. Monepatel is a potent mTor inhibitor so MND is proof of concept but can have much broader utility and thus value!
Monepatel mTor inhibitor MOA
Ann: MND Trial Successfully Completes First Patient Cohort, page-156
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.0¢ |
Change
-0.005(2.70%) |
Mkt cap ! $87.51M | |||
| Open | High | Low | Value | Volume |
| 18.5¢ | 18.5¢ | 18.0¢ | $61.10K | 337.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 132291 | 18.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.5¢ | 146840 | 4 |
View Market Depth
| Last trade - 15.58pm 28/08/2024 (20 minute delay) ? |
| PAA (ASX) Chart |